Why the study?
There is an ongoing need to better understand the unique cardiovascular manifestations of COVID-19 and its associated arrhythmias.
This review highlights that COVID-19 is associated with specific arrhythmias, including acute sinus bradycardia and atrial fibrillation, as well as long-term complications like POTS.
May warrant phase-specific arrhythmia monitoring in COVID-19; leaves open prospective trials on interventions.
The coronavirus pandemic remains a major public health burden with multisystem disease manifestations. There has been an ongoing global effort to better understand the unique cardiovascular manifestations of this disease and its associated arrhythmias. In this review, we summarize the current data on incidence and outcomes of arrhythmias in the acute and convalescent period, possible pathophysiologic mechanisms, and medical management. Sinus bradycardia-reported in multiple observational studies in the acute infectious period-stands out as an unexpected inflammatory response. Atrial fibrillation has been noted as the most common pathologic arrhythmia and has been shown to be a poor prognostic marker in multiple cohorts. In the convalescent period, long-term complications such as postural orthostatic tachycardia syndrome and inappropriate sinus tachycardia have been described.
No takes yet. Share an insight, caveat, or question.
Pandat et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: